Viewing Study NCT06494202



Ignite Creation Date: 2024-07-17 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06494202
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-10
First Post: 2024-07-02

Brief Title: Stroke Rehabilitation A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System
Sponsor: University of Sao Paulo
Organization: University of Sao Paulo

Study Overview

Official Title: Stroke Rehabilitation A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes The main question it aims to answer is

Do patients with ischemic first episode of stroke have central nervous systems consequences due to peripheral and central nervous system sensibilization
Can stroke patients benefit from a systemized and hierarchized rehabilitation program with desensibilization interventions combined with multidisciplinary and educational programs

We will randomize 60 patients 30 in each study arm

Researchers will compare the intervention group with an active control whose treatment is the institutional conventional program to see if innovative desensibilization strategies yield superior results Authors will also investigate the role of genetic polymorphism and ancestrality in the outcome measures

Participants will undertake an innovative or conventional rehabilitation program according to the randomization
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None